In vitro diagnostics (IVD) is the technique of diagnostic test outside the human body in an artificial environment. The IVD market revenue is expected to reach $74.65 billion by 2020, from the market value of $53.32 billion in 2013, at a CAGR of 5.34% during 2014-2020.
2. Int roduct ion
Scope of the Report Key Benefits Key Audiences
3. Descr ipt ion
In vitro diagnostics (IVD) is the technique of diagnostic test outside the human body in an
artificial environment. The IVD market revenue is expected to reach $74.65 billion by 2020,
from the market value of $53.32 billion in 2013, at a CAGR of 5.34% during 2014-2020. The
global IVD market is segmented based on techniques, product type, usability, application,
end user and geography (North America, Europe, Asia Pacific and Rest of World).
Geographically, Asia Pacific is the fastest growing region and very opportune market that
would generate highest revenue by 2020.Increase in the number of chronic and infectious
diseases, and technological advancements are the major driving factors for the market.
Widespread knowledge of healthcare & its benefits, and cost effectiveness are some top
impacting factors of the global IVD market.
The stringent regulatory policies and reimbursement issues are limiting the growth of the
market. Furthermore, the rising demand for technologically advanced diagnosis devices and
increased spending capabilities of consumers on health care provides huge potential for IVD
in Asia Pacific market.
4. KEY BENE F I T S
Assessments are made according to the current business scenario and the future market trends
are forecast for the period 2013-2020, with the base figures of the year 2013
The analysis gives a wider view of the global market including its market trends, market
structure, limiting factors and opportunities for the market
Porter’s five force’s model helps in analyzing the potential of buyers & suppliers, and the
competitive sketch of the market, which would guide the market players to develop strategies
accordingly
The value chain analysis provides a systematic study on the key intermediaries involved, which
would in turn help the stakeholders in the market to make appropriate strategies
The advantages of the market are analyzed to help the stakeholders identify the opportunistic
areas in a comprehensive manner
5. In Vi t ro Diagnos t ics Mar ket Anal ys i s
IVD ApplicationsMarket Analysis
The application area is segmented based on infectious diseases, diabetes, cancer/oncology,
cardiology, autoimmune diseases, nephrology, drug testing, HIV/AIDS and others. Infectious
diseases generated the highest revenue for current and forecast period mainly due to rise in the
incidences of infectious diseases. HIV/AIDS application market is the second largest revenue
generating applications segment and would remain the second largest through 2020.
IVD End UserMarket Analysis
Hospitals, laboratories, academics, point of care testing and others are the end users of global IVD
market. Academic institutions provide trainings of IVD to the students. Laboratories generate the
highest revenue followed by point of care for global end user market. Rise in the number of
laboratories in Asia Pacific regions and increased awareness about health care and its benefits are
contributing towards the growth of laboratories market, which in turn drives the global IVD end
users market.
IVD GeographyMarket Analysis
The detailed analysis of the global IVD market is done in various regions such as North America,
Europe, Asia Pacific and Rest of World. North America is the largest revenue generating region in all
segments of global IVD market, whereas Asia Pacific region is fastest growing region amongst the
regions studied.
6. In Vi t ro Diagnos t ics Mar ket Anal ys i s
IVD Techniques Market Analysis
Global IVD techniques market is been segmented based on immunoassays, clinical chemistry,
point of care, molecular diagnostics, hematology, coagulation, microbiology and other clinical
techniques. Point of care is the highest revenue-generating segment in the overall IVD techniques
market. Molecular diagnostics is the fastest growing technique in the in the overall IVD techniques
market due to its ability to detect the primary cause of the disease accurately
IVD Product Type Market Analysis
The product type segment is been segmented based on instruments, reagents, data management
systems and services. Instruments hold the highest market share in the global IVD market
followed by reagents. Reagents market is also growing at a faster pace. As it is mostly used in
various equipment and play a key role in the overall diagnosis process. Rise in the usage of
diagnostic devices in which reagents are required for performing diagnosis tests, is the major
factor that drives the product type market.
IVD Usability Market Analysis
Usability segment is classified as disposable and reusable IVD devices. Doctors and clinicians
currently prefer disposable devices, to avoid infections. Still, reusable IVD device holds the largest
revenue share in the global IVD usability market. Cost effectiveness as a benefit of reusable
devices is driving the growth of usability market.
7. IVD Mar ket Compet i t ive Anal ys i s
& High Level Anal ys i s
IVD Competitive Analysis
The study of top ten players in the global market reveals strategies adopted to maintain their
position in the competitive market. Strategic analysis of the top players reveals that market
players are adopting product launch as their key developmental strategy in the market, as the
market players are innovating novel products to expand their product line. Acquisitions and
approvals are some additional strategies adopted by the companies in the market to enhance
their services and expand their reach across the globe.
IVD High Level Analysis
The market exploration provides a clear view of global IVD market. Porter’s five-force model helps
in analyzing market players, new entrants in the market and the novel strategies adopted by
them. In the current business scenario, IVD market has moderate bargaining power of supplier
due to existence of brand loyalty. Varying product differentiation would lead to moderate buyers’
bargaining. High entry barriers lead to lower threat of new entrants. Intersegment substitution
leads to lower threat of Substitute. The value chain analysis reveals the key intermediaries
involved in the supply chain. Raw material suppliers, medical device manufacturers, distributors,
service providers and end users are the various stakeholders involved in the supply chain of IVD
market.
8. Table of Content s
1. Introduction
2. Executive Summary
3. Market Overview
4. Global IVD Market by Techniques
5. Global IVD Market by Product Type
6. Global IVD Market by Usability
7. Global IVD Market by Application
8. Global IVD Market by End Users
9. Global IVD Market by Geography
10. Company Profiles
9. Global In Vi t ro Diagnos t ics
Mar ket Overv iew
Market
dynamics
In Vitro
Diagnostics
Market
Overview
Key
technology
trends
Porter five
forces model
Value chain
analysis
Market
Definition and
Scope
Key findings
Government
regulations
Case studies
10. Market Dynamics
Mar ket Dynamics
Key Market
Drivers
Market
Restraints
Unclear
reimbursement
policies
Increasing
government
expenditures
on healthcare
Emergence of
minimal
invasive
technologies
Technological
advancements
in IVD
Increasing
incidences of
chronic and
infectious
diseases
Stringent
Regulatory
policies
11. IN VI TRO DIAGNOS T ICS MARKE T
BY END US ER
IN VITRO
DIAGNOSTICS
MARKET
BY
END USER
Hospitals
Laboratory
Academics
Point-of-Care Testing
Others
Others
12. GLOBAL IN VI TRO DIAGNOS T ICS
MARKE T BY PRODUCT TYPE
Instrum
ents
IN VITRO
DIAGNOSTIC
MARKET
BY
PRODUCT
TYPE
Reagents
Data
manage
ment
system
Services
13. IN VI TRO DIAGNOS T ICS MARKE T
BY, TECHNIQUE S
Hematology Clinical chemistry
Coagulation
Molecular
diagnostics
Microbiology
Immunoassay/
Immunochemistry
14. In Vi t ro Diagnos t ics Mar ket
by Appl icat ions
Infectious diseases
Diabetes
Cancer/Oncology
Cardiology
Autoimmune diseases
Nephrology
Drug testing
HIV/AIDS
Others
15. Top Mar ket Player s of In Vi t ro
Diagnos t ics Mar ket
Alerc Inc
Biomerisux
Danaher Corporation
Roche Diagnostics
Becton Dickinson and Company
Bio-Rad Laboratories
Abbott Laboratories
Bayon AG
Arkray Inc
Sysmex
Johnson & Johnson
Siemens
16. Thank You!
For More Details
Visit us at
http://www.alliedmarketresearch.com/ivd-in-vitro-diagnostics-market
Follow Us On